Eligibility and Safety of Triple Therapy for Hepatitis C: Lessons Learned from the First Experience in a Real World Setting

Por Maasoumy, Benjamin, Port, Kerstin, Markova, Antoaneta Angelova, Serrano, Beatriz Calle, Rogalska-Taranta, Magdalena, Sollik, Lisa, Mix, Carola, Kirschner, Janina, Manns, Michael P., Wedemeyer, Heiner, Cornberg, Markus
Publicado em 2013

Anti-HDV IgM as a Marker of Disease Activity in Hepatitis Delta

Por Wranke, Anika, Heidrich, Benjamin, Ernst, Stefanie, Calle Serrano, Beatriz, Caruntu, Florin Alexandru, Curescu, Manuela Gabriela, Yalcin, Kendal, Gürel, Selim, Zeuzem, Stefan, Erhardt, Andreas, Lüth, Stefan, Papatheodoridis, George V., Bremer, Birgit, Stift, Judith, Grabowski, Jan, Kirschner, Janina, Port, Kerstin, Cornberg, Markus, Falk, Christine S., Dienes, Hans-Peter, Hardtke, Svenja, Manns, Michael P., Yurdaydin, Cihan, Wedemeyer, Heiner
Publicado em 2014